Card image cap

Diana DeGette's Public Statements on Issue: Drugs

Office:

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 4
Date Title
12/07/2021 Letter to Hon. Chuck Schumer, Majority Leader US Senate - Keep Affordable Insulin Measures in Build Back Better Act
04/26/2021 Letter to Rosa DeLauro, Chairwoman of House Appropriations Subcommittee on Labor, Health and Human Services, and Education and Tom Cole, Ranking Member of House Appropriations Subcommittee on Labor, Health and Human Services, and Education - Neguse, Armstrong Urge Protection of Cannabis Research in Appropriations Process
09/29/2020 House Approves De Gette Anti-Doping Bill Ahead of 2028 Olympic Games
08/11/2020 Letter to Alex Azar, Secretary of Health and Human Serivces - Lawmakers raise concerns over the pandemic's effect on the nation's opioid crisis
08/11/2020 Letter to the Hon. Alex Azar, Secretary of the Dept. of Health and Human Services - Bipartisan Committee Leaders Request Information on COVID-19's Impact on Addiction & Overdose Crisis
01/23/2020 Engel, DeGette Lead Over 50 House Colleagues in Demanding Complete Ban on E-Cigarettes
01/23/2020 Letter to Alex Azar, Secretary of the Department of Health and Human Services - Lawmakers Call on Administration to Ban Flavored Vaping Products
01/22/2020 Lawmakers Prepare to Grill E-Cigarette Makers Over Role in Teen-Vaping Epidemic
01/14/2020 Lawmakers Raise Concerns Over Increased Use of Cocaine and Methamphetamine
01/13/2020 Key House Oversight Panel to Hear From State Officials on Front Lines of Fight to Curb Opioid Epidemic
12/10/2019 Thompson, DeGette, Johnson Introduce Bipartisan Bill to Reauthorize USADA
09/18/2019 Letter to the Hon. Ron DeSantis, Governor of Florida, the Hon. Eric Holcomb, Governor of Indiana, the Hon. Matt Bevin, Governor of Kentucky, the Hon. Janet Mills, Governor of Maine, the Hon. Larry Hogan, Governor of Maryland, the Hon. Charlie Baker, Governor of Massachusetts, Michelle Lujan Grisham, Governor of New Mexico, the Hon. Andrew Cuomo, Governor of New York, the Hon. Roy Cooper, Governor of North Carolina, the Hon. Mike DeWine, Governor of Ohio, the Hon. Kate Brown, Governor of Oregon, the Hon. Tom Wolf, Governor of Pennsylvania, the Hon. Gina Raimondo, Governor of Rhode Island, the Hon. Bill Lee, Governor of Tennessee, the Hon. Jim Justice, Governor of West Virginia, and the Hon. Tony Evers, Governor of Wisconsin - E&C bipartisan leaders seek information from states on use of federal funds to respond to opioid crisis
07/16/2019 De Gette Calls for New "National Strategy' to Combat Fentanyl Epidemic
07/09/2019 House Oversight panel to investigate administration's efforts to curb flow of fentanyl into U.S.
06/25/2019 Letter to the Hon. Norma Sharpless, Acting Commissioner of the Food and Drug Administration - Bipartisan E&C Leaders Request FDA Briefing on Opioids
06/13/2019 Letter to Various Federal Agencies - Bipartisan E&C Leaders Request Briefings on Ongoing Threat Posed by Fentanyl from Six Federal Agencies
06/13/2019 Letter to the Hon. Kevin McAleenan, James Carroll, Utlam Dhillon, Megan Brennan, Michael Pompeo, and Norman Sharpless - Bipartisan E&C Leaders Request Briefings on Ongoing Threat Posed by Fentanyl From Six Federal Agencies
05/02/2019 Colorado lawmakers call for change in rules barring naturalization of immigrants who work in cannabis industry
05/02/2019 Neguse Leads Letter with Colorado Delegation Members Supporting Immigrants Working in Cannabis Industry
04/01/2019 DeGette introduces bill aimed at bringing down cost of insulin
04/01/2019 DeGette introduces bill to block feds from enforcing marijuana laws in states where its legal
02/25/2019 House Passes Brooks, Engel, DeGette, Herrera Beutler Poison Control Bill
02/12/2019 Letter to Scott Gottlieb, Commissioner U.S. Food and Drug Administration - DeGette, Markey demand documents from FDA on approval of new opioid painkiller Dsuvia
01/30/2019 Letter to Doug Langa, President of Novo Nordisk Inc. - DeGette, Pallone demand answers on rising cost of insulin
01/30/2019 Letter to Olivier Brandicourt, CEO of Sanofi - DeGette, Pallone demand answers on rising cost of insulin
Page 1 of 4
arrow_upward